Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Sign Up to like & getrecommendations! Published in 2019 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2019.01.012
Abstract: BACKGROUND Mycobacterium kansasii is a major pathogen associated with nontuberculous mycobacterial pulmonary disease. For treatment of M. kansasii pulmonary disease, daily therapy with isoniazid, rifampin, and ethambutol is traditionally recommended. Although a regimen containing a… read more here.
Keywords: kansasii pulmonary; containing regimen; treatment; group ... See more keywords